Panagora Asset Management Inc Intra Cellular Therapies, Inc. Transaction History

Panagora Asset Management Inc

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	BUY	$64.37 - $75.65 $1.96 Million - $2.3 Million	30,450 Added 452.52%	37,179 $2.57 Million
Q4 2023 Feb 08, 2024	BUY	$46.37 - $73.65 $312,023 - $495,590	6,729 New	6,729 $481,000
Q4 2022 Feb 13, 2023	SELL	$44.07 - $54.45 $163,323 - $201,791	-3,706 Reduced 19.17%	15,627 $826,000
Q3 2022 Nov 14, 2022	BUY	$42.7 - $59.99 $896 - $1,259	21 Added 0.11%	19,333 $900,000
Q2 2022 Aug 15, 2022	BUY	$43.0 - $65.64 $830,416 - $1.27 Million	19,312 New	19,312 $1.1 Million
Q4 2020 Feb 10, 2021	SELL	$23.34 - $32.22 $88,551 - $122,242	-3,794 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$12.31 - $33.12 $46,704 - $125,657	3,794 New	3,794 $58,000
Q4 2019 Feb 12, 2020	SELL	$7.26 - $38.49 $67,227 - $356,417	-9,260 Closed	0 $0
Q3 2019 Nov 12, 2019	SELL	$7.47 - $14.03 $263,758 - $495,385	-35,309 Reduced 79.22%	9,260 $69,000
Q1 2019 May 15, 2019	SELL	$10.9 - $14.09 $828 - $1,070	-76 Reduced 0.17%	44,569 $543,000
Q3 2018 Nov 13, 2018	SELL	$17.77 - $22.9 $2.9 Million - $3.74 Million	-163,290 Reduced 78.53%	44,645 $969,000
Q2 2018 Aug 14, 2018	SELL	$17.33 - $23.4 $574,662 - $775,944	-33,160 Reduced 13.75%	207,935 $3.67 Million
Q1 2018 May 15, 2018	BUY	$15.16 - $25.49 $563,785 - $947,947	37,189 Added 18.24%	241,095 $5.08 Million
Q4 2017 Feb 14, 2018	BUY	$14.27 - $16.79 $1.5 Million - $1.76 Million	104,882 Added 105.92%	203,906 $2.95 Million
Q3 2017 Nov 14, 2017	BUY	$10.77 - $22.1 $1.07 Million - $2.19 Million	99,024	99,024 $1.56 Million

381

84M

319K

143K

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $11.9B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Panagora Asset Management Inc with notifications on news.